dactinomycin has been researched along with B16 Melanoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladelfa, MF; Laiseca, JE; Mano, M; Monte, M; Peche, LY; Schneider, C; Toledo, MF | 1 |
| He, GW; Kamei, K; Lee, KB; Radu, CG; Shu, CJ; Silverman, R; Takahashi, H; Tseng, HR; Wang, X; Witte, ON; Yu, ZT | 1 |
| Henderson, BR; Kühn, LC | 1 |
| Azure, M; Chowdhary, I; Cieszka, K; Hill, GJ; Hill, HZ; Sayre, RM | 1 |
| Behrens, CH; Behrens, DL; Chen, SF; Fredericks, JR; Kirshenbaum, MR; Papp, LM; Polkus, ST; Sipple, P; Stafford, MM; Sun, JH | 1 |
| Feleszko, W; Giermasz, A; Gołab, J; Jakóbisiak, M; Kuc, K; Lasek, W; Stokłosa, T; Wańkowicz, A; Zagozdzon, R | 1 |
| Desai, D; Niles, RM; Quick, TC; Xiao, Y | 1 |
| Daly, JM; Evoy, DA; Hill, AD; Mack, VE; McCarter, MD; Naama, HA; Shou, J | 1 |
| Brocard, MP; Grunwald, D; Khochbin, S; Lawrence, JJ | 1 |
| Hanada, M; Hatori, M; Kamei, H; Konishi, M; Nishiyama, Y; Sugawara, K | 1 |
| Castrucci, AM; Hadley, ME; Jiang, JW; Marwan, MM | 1 |
| Kelley, KW; Lorence, RM; Rood, PA | 1 |
| Kasuga, T; Kuwashima, Y; Matsubara, O | 1 |
| Carland, KC; Kline, EL; Smith, TJ; Warren, JT | 1 |
14 other study(ies) available for dactinomycin and B16 Melanoma
| Article | Year |
|---|---|
Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Cycle; Cell Nucleolus; Cell Proliferation; Dactinomycin; E2F Transcription Factors; Fibroblasts; Gene Expression Regulation; Green Fluorescent Proteins; HCT116 Cells; HEK293 Cells; Histone Deacetylase 1; Histone Deacetylases; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Proto-Oncogene Proteins c-mdm2; Ribosomes | 2015 |
Integrated microfluidic devices for combinatorial cell-based assays.
Topics: Animals; Annexin A5; Antibiotics, Antineoplastic; Apoptosis; Bioreactors; Cell Culture Techniques; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Equipment Design; Fibroblasts; Fibronectins; Genes, Reporter; Green Fluorescent Proteins; HeLa Cells; Humans; Melanoma, Experimental; Mice; Microfluidic Analytical Techniques; NIH 3T3 Cells; Staurosporine; Transcriptional Activation; Transfection | 2009 |
Differential modulation of the RNA-binding proteins IRP-1 and IRP-2 in response to iron. IRP-2 inactivation requires translation of another protein.
Topics: 3T3 Cells; Animals; Cycloheximide; Cytidine Triphosphate; Dactinomycin; Deferoxamine; Iron; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Iron-Regulatory Proteins; Kinetics; L Cells; Melanoma, Experimental; Mercaptoethanol; Mice; Models, Structural; Protein Biosynthesis; RNA; RNA-Binding Proteins; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
A multitherapy resistance factor from melanoma reveals that killing by near UV is different from genotoxic agents.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line; Dactinomycin; Drug Resistance, Multiple; Gamma Rays; Melanoma, Experimental; Mice; Mitomycin; Tumor Cells, Cultured; Ultraviolet Rays; Vinblastine | 1995 |
(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Isoquinolines; KB Cells; Kinetics; Leucine; Leukemia L1210; Leukemia P388; Mammary Neoplasms, Experimental; Melanoma; Melanoma, Experimental; Mesylates; Mice; Mitoxantrone; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured; Uridine | 1994 |
Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Dactinomycin; Drug Synergism; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Sarcoma, Experimental; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Control of retinoic acid receptor expression in mouse melanoma cells by cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Blotting, Northern; Cyclic AMP; Cycloheximide; Dactinomycin; DNA; DNA Probes; DNA, Complementary; Gene Expression Regulation, Neoplastic; Genes, Reporter; Luciferases; Melanoma, Experimental; Mice; Nuclear Proteins; Protein Kinase C; Receptors, Retinoic Acid; RNA, Messenger; Tretinoin; Tumor Cells, Cultured | 1996 |
Suppression of macrophage nitric oxide production by melanoma: mediation by a melanoma-derived product.
Topics: Animals; Coculture Techniques; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Female; Macrophages; Macrophages, Peritoneal; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Nitric Oxide; Peritoneum; RNA; Time Factors; Tumor Cells, Cultured | 2001 |
Antisense RNA and p53 regulation in induced murine cell differentiation.
Topics: Animals; Cell Differentiation; Dactinomycin; Down-Regulation; Gene Expression Regulation, Neoplastic; Melanoma, Experimental; Mice; Models, Genetic; Repetitive Sequences, Nucleic Acid; RNA Precursors; RNA Processing, Post-Transcriptional; RNA, Antisense; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1992 |
Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins.
Topics: Amino Acid Sequence; Amino Acids; Animals; Antibiotics, Antineoplastic; Bacteria; Carcinoma; Chromatography, Thin Layer; Colorectal Neoplasms; Dactinomycin; Female; Fermentation; Fungi; Humans; Hydrolysis; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Melanoma, Experimental; Mice; Molecular Sequence Data; Molecular Structure; Oligopeptides; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Streptomyces; Tumor Cells, Cultured | 1992 |
Psoralens stimulate mouse melanocyte and melanoma tyrosinase activity in the absence of ultraviolet light.
Topics: Administration, Cutaneous; Animals; Cycloheximide; Dactinomycin; Furocoumarins; Melanocytes; Melanoma, Experimental; Methoxsalen; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Rana pipiens; Tumor Cells, Cultured | 1990 |
Serum protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by recombinant tumor necrosis factors alpha and beta.
Topics: Amino Acid Chloromethyl Ketones; Animals; Cell Survival; Dactinomycin; In Vitro Techniques; Melanoma, Experimental; Mice; Newcastle disease virus; Recombinant Proteins; Serine Endopeptidases; Time Factors; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Responses of a murine B16 melanoma to pharmacotherapy studied and compared with different assay systems.
Topics: Animals; Cell Survival; Cyclophosphamide; Dactinomycin; Doxorubicin; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitotic Index; Tumor Cells, Cultured | 1990 |
Effect of testosterone on imidazole-induced tyrosinase expression in B16 melanoma cell culture.
Topics: Animals; Cycloheximide; Dactinomycin; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Induction; Epitestosterone; Imidazoles; Melanoma, Experimental; Mice; Testosterone; Tumor Cells, Cultured | 1988 |